[ET Net News Agency, 1 April 2026] INNOCARE (09969) rose 10% to HK$14.91.
It hits an intra-day high of HK$14.93, hitting an 1-month high, breaking above the 250-D SMA of HK$13.759, and an intra-day low of HK$13.77. The total shares traded was 9.97 million, with a value of HK$143.52m. The active buy/sell ratio is 75:25, with net buying turnover of HK$69.74m. HSBC SEC BRO (ASIA) accounts for greatest net responsive buying turnover of HK$1.8m, with volume weighted average price of HK$14.315. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$18.32m, with volume weighted average price of HK$14.406.
Basic Information| Nominal | 14.910 | % Chg | +9.96% |
| High | 14.930 | Low | 13.770 |
| Shares Tr | 9.97m | Turnover | 143.52m |
| 10-D SMA | 12.846 | %H.V | 43.766 |
| 20-D SMA | 12.391 | VWAP | 14.402 |
| 50-D SMA | 12.183 | RSI14 | 73.667 |
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is 75:25, with net buying turnover of HK$69.74m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOCARE (09969) | 14.91 | +9.96 |
| INNOVENT BIO (01801) | 90.45 | +6.54 |
| KEYMED BIO-B (02162) | 67.40 | +11.04 |
| XTALPI (02228) | 9.57 | +6.22 |
| WUXI XDC (02268) | 61.05 | +4.90 |
| WUXI BIO (02269) | 34.96 | +5.88 |
| WUXI APPTEC (02359) | 123.30 | +4.94 |
| BEONE MEDICINES (06160) | 184.50 | +7.52 |
| AKESO (09926) | 139.40 | +7.07 |
| REMEGEN (09995) | 109.60 | +14.40 |
(ed)
Nominal 
